Global Nebulizers Market By Type (Pneumatic Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizers), By Application (COPD, Cystic fibrosis, and Asthma), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022–2032

Nebulizers Market Overview:

The global nebulizer market was worth USD 1,100 million in 2021. It is projected to grow at a 7.3% CAGR from 2022 to 2032.

This high growth can be attributed to rising rates of chronic respiratory diseases, rising demand for home health devices, as well as the growing geriatric population. According to the Centers for Disease Control and Prevention (CDC), Chronic Obstructive Pulmonary Disease is the fourth leading cause of death in the U.S.

Global Nebulizer Market Scope:

Type Analysis

The low cost of jet nebulizers made them the most popular in terms of revenue which is 64%. Jet nebulizers have been the most popular segment for years due to their ease of use and effective design for drug delivery. Jet nebulizers can deliver formulations that are not possible to be delivered using dry powder inhalers or pressurized metered-dose inhalers.

There are many options for nebulizers: they come in a variety of designs, including jet nebulizers and corrugated tubes, collection bags, and breath-enhanced or breath-actuated jet nebulizers.

Because of their technologically advanced compact devices and minimal drug loss, the mesh nebulizers market is expected to grow significantly over the forecast period.

Mesh nebulizers are expected to continue growing, mainly due to patient acceptance, ease of use, portability, convenience, and quick treatment. Market penetration is also being aided by the increasing acceptance of mesh-nebulizers because they deliver drugs to the lungs accurately and have lower residual volumes.

End-Use Analysis

Hospitals and clinics accounted for 64.8% of the total revenue in 2021. This is due to favorable reimbursement policies and higher patient footfall. Hospitals are an integral part of the healthcare industry and provide the industry’s largest revenue source.

Multiple companies spend significant efforts to promote their products/services in hospitals.

Cipla Limited announced in 2021 a plan to increase access to nebulization therapy in rural India for acute asthma management. These projects help to boost segment growth.

In recent years, home healthcare devices have gained popularity and market share. The adoption of home healthcare devices is increasing due to technological advances and the minimization of product sizes.

Home healthcare devices will be driven by the increasing geriatric population, rising incidence of target diseases, and the need to reduce healthcare spending.

The market is expected to grow because home healthcare is an affordable alternative to costly hospital stays.

Home healthcare is becoming more popular due to the availability of small nebulizers, which are easy to use. Technological innovations in nebulizers are also increasing their popularity.

Key Market Segments:

By Type

•  Jet
•  Mesh
•  Ultrasonic

By End-Use

•  Hospitals & Clinics
•  Emergency Centers
•  Home Healthcare

Market Dynamics:

The rising prevalence of respiratory disease in North America is also due to the increased consumption of alcohol, cigarettes, as well as ultra-processed beverages such as sugar-sweetened drinks. The Centers for Disease Control and Prevention data show that tobacco use is responsible for approximately 13% of all deaths among adults between 30 and 70 in North America.

The demand for nebulizers will rise as a result of increased smoking and environmental pollution. According to the WHO, there were 323 million COPD-related deaths in 2019.

Initiatives such as the “Global Alliance against Chronic Respiratory Diseases,” which aims to improve the diagnosis and treatment of respiratory disorders, may drive the market for nasal nebulizers.

Millions of people have been affected by the COVID-19 pandemic. The global pandemic forced healthcare professionals to rush to find preventive and therapeutic solutions.

Patients with COPD or asthma who knew about the possibility of COVID-19 being airborne were cautious about using an inhaled medication, as they are potentially a source of virus transmission and immunosuppression.

All patients with COPD or asthma were advised by medical professionals to continue taking their prescribed inhaled medications. When albuterol inhalers were in short supply, nebulized albuterol was offered as an alternative.
Many pharmaceutical companies are also focusing their efforts on the development of effective COVID-19 treatments. These will primarily be administered via a Nebulizer.

Vectura and Inspira Pharmaceuticals announced a partnership in May 2021 to develop an inhalation-based COVID-19 treatment. Vectura will use its FOX vibrating wire nebulizer to test the IPX formulation’s delivery to the lungs.

The market for respiratory devices and nebulizers is mature. Due to its low cost, the jet segment dominates the market.

Other nebulization products will likely face high competition. It is difficult for new technology and devices to gain momentum in mature markets due to the complexity of national regulatory systems and reimbursements that must be followed for both drugs and devices.

Regional Analysis

North America accounted for the highest revenue share, at over 31%, in 2021. This is due to the growing number of respiratory diseases and government efforts such as favorable reimbursement scenarios, customer awareness, and a well-established healthcare infrastructure.

This region will see a rise in demand for technologically advanced products and favorable reimbursement policies. A rise in the U.S. geriatric population is leading to an increase in the number of surgeries, which further increases the region’s market growth.

In the next 40 years, Americans 65 years and older will double, with 80 million expected to be in 2040.

The Asia Pacific will be the fastest-growing regional market during the forecast period. This is due to the large geriatric population and increased focus on preventive health care.

Government initiatives to promote technological innovation are also contributing to this growth.

These devices are in high demand due to a rise in healthcare spending and increased patient awareness. This market has been attracted to by foreign players because of the low-cost manufacturing locations and favorable taxation policies.

The region’s market has also seen a rise in medical tourism to countries like India, Malaysia, Singapore, and the Philippines.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

Due to the present major players, the market for nebulizers has matured. The introduction of mesh nebulizers that are technologically advanced has opened up many new opportunities for companies like Vectura Group or PARI Pharma.

Mesh nebulizers are being used by many pharmaceutical companies for drug development. According to the European and American clinical trial databases, the mesh is preferred over jet nebulizers for drug development clinical trials.

Companies are pursuing strategies to differentiate their products from other market players. These include new product development, acquisitions, and collaborations with other players and research institutes. In China, HCmed Innovations Co., Ltd. brought Pulmogine to market in 2020.

Similarly, OMRON Corporation also announced in January 2020 the opening of ATC-TOKYO in Tokyo.

Customers can now join the company and find solutions to any manufacturing problems with this center. The following are some of the most prominent players in global nebulizer markets:

Маrkеt Кеу Рlауеrѕ:

•  Omron Corporation
•  GE Healthcare
•  Koninklijke Philips N.V.
•  Allied Healthcare
•  Vectura Group Plc.
•  PARI Respiratory Equipment, Inc.
•  Aerogen
•  DeVilbiss Healthcare LLC
•  Briggs Healthcare
•  Beurer GmBH
•  Other Key Players

For the Nebulizers Market research study, the following years have been considered to estimate the market size: